Vascular Genesis is a biotechnology startup based in the United States, founded in 2016. The company is focused on revolutionizing the vascular conduit replacement market with its innovative line of synthetic scaffold products. These products boast self-healing capabilities that significantly lower the risks associated with traditional vascular conduit replacements, including rejection, infection, and stenosis. The company's most recent milestone was its Seed Round investment on 30 May 2017, where it secured funding from Ikove Capital Partners, John D'Orazio, and Proton Enterprises. Vascular Genesis's technology and products address critical needs in the medical device industry, offering promising solutions to enhance patient outcomes and minimize potential complications. With a strong focus on innovation and product development, the company has the potential to make a significant impact in the field of vascular health and could attract further interest from investors and strategic partners in the biotechnology and medical sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 3 |
|
30 May 2017 |
No recent news or press coverage available for Vascular Genesis.
We care about your data, and we'd love to use cookies make your experience better.
